SMAD4 and hepatocellular carcinoma: Taken together, Smad4 deficiency in hepatocytes promotes the infiltration of CD8+ T cell along with the decrease of MDSCs in transplanted tumors, DEN/CCl4-induced HCC tumors and CCl4-induced fibrotic livers, suggesting that Smad4 promotes immune suppression in the HCC TME.